ALPHABET’S ISOMORPHIC STACKS TWO NEW DEALS WITH LILLY, NOVARTIS WORTH NEARLY $3B AHEAD OF JPM

Summary from the TLDR newsletter

Alphabet's Isomorphic's latest deal will add significant weight to Google DeepMind's AlphaFold AI tech, which predicts protein structures to enable potentially faster target discovery and compound construction. The deals involve identifying small molecule therapies for use against undisclosed targets. The announcements are the first to emerge from the J.P. Morgan Healthcare Conference. The conference will go on until January 11.